We have observed
2 EP applications
Per Jensen Mikkelsen
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 19, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANTIBODIES CAPABLE OF SPECIFICALLY BINDING TWO EPITOPES ON TISSUE FACTOR PATHWAY INHIBITOR
COAGULATION FACTOR IX CONJUGATES